Malaysia grants conditional approval for the Pfizer–BioNTech COVID-19 vaccine to be used as a booster dose for people over the age of 18 years old
Malaysia grants conditional approval for the Pfizer–BioNTech COVID-19 vaccine to be used as a booster dose for people over the age of 18 years old who received their second dose at least six months ago.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthMalaysia grants conditional approval for the Pfizer–BioNTech COVID-19 vaccine to be used as a booster dose for people over the age of 18 years old
View Premium plansBrowse free archive reportsMalaysia grants conditional approval for the Pfizer–BioNTech COVID-19 vaccine to be used as a booster dose for people over the age of 18 years old who received their second dose at least six months ago.